The Familial Hypercholesterolemia (FH) is the most common co-autosomal dominant inherited condition in man. It is mainly caused by mutations in the following three genes: the encoding: the receiver of low-density lipoprotein LDL-C (most common), or apolipoprotein B100 proprotein convertase subutilisina / kexina type 9 (PCSK-9). The resulting chronic elevations in LDL-C levels entail the development of early atherosclerotic cardiovascular disease. The overall estimated prevalence for heterozygous HF ranges from about 1 / 200-250 1/500 and homozygous FH is 1/1 000 000. The childhood is the ideal period of life to discriminate between dyslipidemias FH and not FH. serum LDL-C≥190 mg / dL (2 measures up to 3 months), or LDL-C≥160 mg / dL with a family history of premature coronary disease or high levels of cholesterol increased basal in a parent or LDL -C≥130 mg / dL with positive genetic diagnosis in families may be used as the phenotypic criteria for diagnosis. It is the aim of this study make the early diagnosis of HF in a population sample of children, adolescents and adults Brazilian city of Campinas / SP.
Introduction
The Familial Hypercholesterolemia ( FH) as the most common autosomal condition in man, has its consequences present even in childhood , is indispensable, for the efficient management, early diagnosis of cases. Consequences : chronic elevations in plasma levels of LDL-cholesterol.
Clinical manifestations of FH :
 Early atherosclerotic cardiovascular disease.  A -corneal bow ; B -tendon xanthoma RBM Ago V 71 N 8, Objectives: HF screening in a sample of children and adolescents for early diagnosis and treatment of HF. 
Results and Discussion

Conclusions
The results of this study point to the urgent need for continued FH screening in the population of children and adolescents for their early diagnosis and handling.
